Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center For Human Genetics And Laboratory Diagnostics, |
RCV000853588 | SCV000996555 | likely pathogenic | Hypokalemic periodic paralysis, type 1 | 2023-05-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001310556 | SCV001500410 | likely pathogenic | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | CACNA1S: PM1, PM2, PM5, PP3, PP4 |
Labcorp Genetics |
RCV001869308 | SCV002168517 | pathogenic | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2023-03-09 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 692246). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg897 amino acid residue in CACNA1S. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18835861, 22901280). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CACNA1S protein function. This missense change has been observed in individual(s) with periodic paralysis (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with threonine, which is neutral and polar, at codon 897 of the CACNA1S protein (p.Arg897Thr). |
Genome- |
RCV003453774 | SCV004177831 | likely pathogenic | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000853588 | SCV004177832 | likely pathogenic | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |